Biosortia is modernizing and vastly improving what historically is the most successful approach to drug discovery - a methodology that previously accessed less than 1% we can now effectively open the other 99% to exploration.  

Biotechnology

Biosortia Microbiomics

Ross O. Youngs

David R. Coho

Guy T. Carter

The Advisory Team at Biosortia Microbiomics provides strategic guidance and expert insights to drive the company's innovative drug discovery initiatives. Comprising seasoned advisors, the team leverages its collective expertise to explore untapped microbiomic resources, ensuring the effective and efficient development of transformative medical solutions.

Advisory Team

About

Team members

Other teams at Biosortia Microbiomics

Leadership Team

Operations and Management